C. Rempenault

427 total citations
10 papers, 287 citations indexed

About

C. Rempenault is a scholar working on Rheumatology, Surgery and Health. According to data from OpenAlex, C. Rempenault has authored 10 papers receiving a total of 287 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Rheumatology, 3 papers in Surgery and 2 papers in Health. Recurrent topics in C. Rempenault's work include Rheumatoid Arthritis Research and Therapies (6 papers), Gastrointestinal disorders and treatments (2 papers) and Systemic Lupus Erythematosus Research (2 papers). C. Rempenault is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (6 papers), Gastrointestinal disorders and treatments (2 papers) and Systemic Lupus Erythematosus Research (2 papers). C. Rempenault collaborates with scholars based in France, Switzerland and Australia. C. Rempenault's co-authors include Cédric Lukas, Bernard Combe, Jacques Morel, Thomas Barnetche, C. Hua, C. Gaujoux-Viala, Astrid Herrero, Adeline Ruyssen‐Witrand, Laurence Macia and Thao Pham and has published in prestigious journals such as Annals of the Rheumatic Diseases, Journal of Medical Internet Research and Lara D. Veeken.

In The Last Decade

C. Rempenault

10 papers receiving 281 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
C. Rempenault France	6	188	49	37	32	28	10	287
Léonard de Vinci Kanda Kupa Brazil	10	81 0.4×	19 0.4×	71 1.9×	24 0.8×	43 1.5×	32	228
C Fonnesu Italy	7	70 0.4×	25 0.5×	54 1.5×	19 0.6×	11 0.4×	13	270
Claudia Elera‐Fitzcarrald Peru	9	237 1.3×	5 0.1×	99 2.7×	48 1.5×	24 0.9×	39	298
M. Sheppard United Kingdom	3	37 0.2×	8 0.2×	43 1.2×	18 0.6×	55 2.0×	3	242
H‐C Lin Taiwan	7	44 0.2×	47 1.0×	123 3.3×	9 0.3×	23 0.8×	11	307
Lisa Eisert Germany	10	107 0.6×	7 0.1×	108 2.9×	34 1.1×	12 0.4×	23	312
Juliana Caires de Oliveira Achili Ferreira Brazil	8	98 0.5×	3 0.1×	36 1.0×	12 0.4×	8 0.3×	22	225
Raheel Iftikhar Pakistan	11	23 0.1×	6 0.1×	30 0.8×	108 3.4×	38 1.4×	47	307
Sameh Trabelsi Tunisia	9	30 0.2×	4 0.1×	24 0.6×	34 1.1×	10 0.4×	60	235
Mohammad Hossein Jarahzadeh Iran	10	14 0.1×	10 0.2×	42 1.1×	20 0.6×	9 0.3×	23	229

Countries citing papers authored by C. Rempenault

Since Specialization

Citations

This map shows the geographic impact of C. Rempenault's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Rempenault with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Rempenault more than expected).

Fields of papers citing papers by C. Rempenault

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Rempenault. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Rempenault. The network helps show where C. Rempenault may publish in the future.

Co-authorship network of co-authors of C. Rempenault

This figure shows the co-authorship network connecting the top 25 collaborators of C. Rempenault. A scholar is included among the top collaborators of C. Rempenault based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Rempenault. C. Rempenault is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Rempenault, C., Latifa Noussair, Clara Duran, et al.. (2021). Treatment of bone and joint infections by ceftazidime/avibactam and ceftolozane/tazobactam: a cohort study. Journal of Global Antimicrobial Resistance. 25. 282–286. 14 indexed citations

Rempenault, C., Pierre Corbeau, Laurence Macia, et al.. (2021). CXCR5/CXCL13 pathway, a key driver for migration of regulatory B10 cells, is defective in patients with rheumatoid arthritis. Lara D. Veeken. 61(5). 2185–2196. 15 indexed citations

Jerome, Dana, et al.. (2021). POS0641 INCIDENCE OF GASTRO-INTESTINAL COMPLICATIONS IN RHEUMATOID ARTHRITIS PATIENTS RECEIVING BIOLOGICAL DMARDS IN OBSERVATIONAL COHORT STUDIES: A SYSTEMATIC LITERATURE REVIEW AND META-ANALYSIS. Annals of the Rheumatic Diseases. 80. 559–559. 1 indexed citations

Rempenault, C., Cédric Lukas, Bernard Combe, et al.. (2021). Risk of diverticulitis and gastrointestinal perforation in rheumatoid arthritis treated with tocilizumab compared to rituximab or abatacept. Lara D. Veeken. 61(3). 953–962. 24 indexed citations

Rempenault, C., Cédric Lukas, Anne Tournadre, et al.. (2020). Use of eHealth by Patients With Rheumatoid Arthritis: Observational, Cross-sectional, Multicenter Study. Journal of Medical Internet Research. 23(1). e19998–e19998. 24 indexed citations

Rempenault, C., Anne Tournadre, Pascale Vergne‐Salle, et al.. (2020). THU0581 USE OF EHEALTH BY PATIENTS WITH RHEUMATOID ARTHRITIS: AN OBSERVATIONAL, CROSS SECTIONAL, MULTICENTER STUDY. Annals of the Rheumatic Diseases. 79. 532–533. 2 indexed citations

Rempenault, C., Cédric Lukas, Bernard Combe, et al.. (2020). OP0022 RISK OF DIVERTICULITIS AND GASTRO-INTESTINAL PERFORATION IN RHEUMATOID ARTHRITIS TREATED WITH TOCILIZUMAB COMPARED TO RITUXIMAB AND ABATACEPT: A PROSPECTIVE PROPENSITY-MATCHED COHORT STUDY. Annals of the Rheumatic Diseases. 79. 17–17. 3 indexed citations

Rempenault, C., Thomas Barnetche, Marie‐Elise Truchetet, et al.. (2020). SAT0064 VACCINATION RATE AND RISK FACTORS FOR NON-VACCINATION IN RHEUMATOID ARTHRITIS: A CROSS-SECTIONAL PROSPECTIVE MULTICENTRIC OBSERVATIONAL STUDY. Annals of the Rheumatic Diseases. 79. 965–965. 1 indexed citations

Rempenault, C., Bernard Combe, Thomas Barnetche, et al.. (2019). Clinical and Structural Efficacy of Hydroxychloroquine in Rheumatoid Arthritis: A Systematic Review. Arthritis Care & Research. 72(1). 36–40. 41 indexed citations

10.

Rempenault, C., Bernard Combe, Thomas Barnetche, et al.. (2017). Metabolic and cardiovascular benefits of hydroxychloroquine in patients with rheumatoid arthritis: a systematic review and meta-analysis. Annals of the Rheumatic Diseases. 77(1). 98–103. 162 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact